Medtronic plc (MDT) Q2 2021 Earnings Results

Medtronic Beats on EPS, Stock Up 2.78%

Medtronic's strong EPS performance, exceeding expectations by 30.6%, contributed to a positive stock reaction, with shares rising 2.78%. This suggests investor confidence in the company's ability to manage through current market conditions. However, the lack of revenue data and guidance leaves some uncertainty about future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.02	N/A	+30.60%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about future growth. They emphasized the resilience of their product lines amid market challenges.

Management highlighted strong performance in key product areas despite ongoing challenges.

They expressed confidence in the company's ability to navigate the current market environment.

Medtronic Beats on EPS, Stock Up 2.78%

Key numbers

Management commentary

Medtronic plc

More earnings this week

Medtronic Beats on EPS, Stock Up 2.78%

Key numbers

Management commentary